Ochronosis: Difference between revisions
CSV import |
CSV import |
||
| Line 23: | Line 23: | ||
{{stub}} | {{stub}} | ||
<gallery> | |||
File:Homogentisic_acid.svg|Homogentisic acid structure | |||
File:Hellocker-_Pigment.JPG|Pigment deposition in ochronosis | |||
File:Inborn_errors_of_metabolism_of_phenylalanine_and_tyrosine.svg|Metabolic pathway of phenylalanine and tyrosine | |||
</gallery> | |||
Revision as of 04:12, 18 February 2025
Ochronosis is a metabolic disorder characterized by the accumulation of homogentisic acid in connective tissues. It is a rare condition, often associated with Alkaptonuria, a metabolic disorder that affects the body's ability to break down certain amino acids.
Symptoms
The most common symptom of Ochronosis is darkening of the skin, particularly in areas exposed to the sun. Other symptoms may include arthritis, heart disease, and kidney stones. The severity of symptoms can vary widely among individuals with the condition.
Causes
Ochronosis is caused by a deficiency in the enzyme homogentisate 1,2-dioxygenase, which is involved in the breakdown of the amino acids phenylalanine and tyrosine. This deficiency leads to the accumulation of homogentisic acid in the body, which can cause damage to connective tissues.
Diagnosis
Diagnosis of Ochronosis is typically based on the presence of characteristic symptoms, such as darkening of the skin and arthritis. Laboratory tests can also be used to measure the levels of homogentisic acid in the urine.
Treatment
There is currently no cure for Ochronosis, but treatment can help manage symptoms. This may include pain management for arthritis and lifestyle changes to prevent kidney stones.


